Grace Therapeutics, Inc. (GRCE)
Operating Cash Flow Growth
21.42%
TTM · Period ending:
GRCE Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported21.42%period ending
Latest reported21.42%period ending
GRCE TTM Cash from Operations YoY % (-0.26% → 21.42%)
Year-over-year change
High-resolution chart · PNG
GRCE operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 21.4232% | |
| 40.4144% | |
| 27.853% | |
| -1.7743% | |
| -35.2978% | |
| -20.8465% | |
| -3.4412% | |
| 23.2842% | |
| 42.0757% | |
| 22.4973% | |
| 13.7363% | |
| 7.1893% | |
| 13.1471% | |
| 11.7863% | |
| 8.0277% | |
| 7.3061% | |
| -10.9569% | |
| 4.0739% | |
| 15.1439% | |
| 18.1853% | |
| 22.767% | |
| 20.4635% | |
| 33.15% | |
| 27.9443% | |
| 23.257% | |
| 11.5837% | |
| -42.7419% | |
| -75.0526% | |
| -110.1018% | |
| -144.8127% | |
| -170.5619% | |
| -249.4024% | |
| -184.8664% | |
| -61.7531% | |
| -5.5559% | |
| 14.6936% | |
| 11.9475% | |
| 24.2625% | |
| 7.1536% | |
| 16.0325% | |
| 33.633% | |
| 12.8717% | |
| -8.4855% | |
| 4.5718% | |
| -345.89% | |
| -340.3187% | |
| -107.3843% | |
| -149.0926% | |
| 54.1% | |
| 75.6753% | |
| 53.5379% | |
| 56.7506% | |
| 11.4466% | |
| -155.6563% | |
| -168.8079% | |
| -199.0779% | |
| -137.586% | |
| -105.9316% | |
| -78.7257% | |
| -0.2582% |